Spotlight on nutrition and pharma start-ups to support GLP-1 consumers
The rise of GLP-1 medications for metabolic health and weight loss is sparking innovations in nutrition and pharmaceuticals. Start-ups, alongside...
Pharma
Zealand Pharma and OTR to focus on metabolic disease
Zealand Pharma will take on the responsibility for clinical development, regulatory submissions and global commercialisation. Credit: T. Schneider/Shutterstock.com. Zealand Pharma...
Zealand Pharma outlines Metabolic Frontier 2030 strategy to
Press release – No. 19 / 2025 Zealand Pharma outlines Metabolic Frontier 2030 strategy to become a generational biotech leader...
